Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C

被引：1
|
作者：
Soza, A [1 ]
Hoofnagle, JH [1 ]
机构：
[1] NIDDKD, Liver Dis Sect, Digest Dis Branch, NIH, Bethesda, MD 20892 USA
来源：
HEPATOLOGY | 2003年 / 38卷 / 01期
关键词：
D O I：
10.1053/jhep.2003.50213
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [31] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [32] Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
    Yasuji Arase
    Kenji Ikeda
    Fumitaka Suzuki
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Masahiro Kobayashi
    Norio Akuta
    Takashi Someya
    Tetsuya Hosaka
    Hitomi Sezaki
    Mariko Kobayashi
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 1090 - 1094
  • [33] Comparison of combination therapy of pegylated interferon and ribavirin with conventional interferon and ribavirin in chronic hepatitis C in Korea
    Kang, Myoung Joo
    Jung, Eun Uk
    Park, Sang Won
    Choi, Paul
    Kim, Ji Hyun
    Park, Sung Jae
    Park, Eun Taek
    Lee, Youn Jae
    Lee, Sang Hyuk
    Seol, Sang Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A217 - A217
  • [34] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Rosen, Irit
    Kori, Michal
    Adiv, Orly Eshach
    Yerushalmi, Baruch
    Zion, Nataly
    Shaoul, Ron
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1098 - 1103
  • [35] Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
    Arase, Y
    Ikeda, K
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (11) : 1090 - 1094
  • [36] Interstitial pneumonitis during combination therapy with interferon-α and ribavirin in a patient with chronic hepatitis C
    Rothfuss, KS
    Bode, JC
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2002, 40 (09): : 807 - 810
  • [37] Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon
    Cozzolongo, R
    Cuppone, R
    Giannuzzi, V
    Amati, L
    Caradonna, L
    Tamborrino, V
    Jirillo, E
    Manghisi, OG
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 129 - 135
  • [38] Interferon alfa-2a in combination with ribavirin and amantadine (triple therapy) in hepatitis C patients with previous non-response or relapse to interferon alfa and ribavirin combination therapy.
    Reichard, O
    Lindahl, K
    Schvarcz, R
    Uhnoo, I
    Shev, S
    Carlsson, T
    Wejstal, R
    HEPATOLOGY, 1999, 30 (04) : 372A - 372A
  • [39] High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus
    Sookoian, S
    Neglia, V
    Castaño, G
    Frider, B
    Kien, MC
    Chohuela, E
    ARCHIVES OF DERMATOLOGY, 1999, 135 (08) : 1000 - 1001
  • [40] Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
    Rodriguez-Lojo, R.
    Almagro, M.
    Barja, J. M.
    Pineyro, F.
    Perez-Varela, L.
    Del Pozo, J.
    Yebra-Pimentel, M. T.
    Fonseca, E.
    DERMATOLOGY RESEARCH AND PRACTICE, 2010, 2010
12345